JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2020 Results - Earnings Call Transcript
Jazz Pharmaceuticals plc (JAZZ) Q4 2020 Earnings Conference Call February 23, 2021 04:30 PM ET Company Participants Andrea Flynn - Head of Investor Relations Bruce Cozadd - Chief Executive Officer Renée Galá - Chief Financial Officer Dan Swisher - President Rob Iannone - Executive Vice President of R&D and Chief Medical Officer Kim Sablich - Executive Vice President, General Manager of North America Phil Jochelson - Neuroscience Therapeutic Head Jed Black - Senior Vice President of Sleep and Neuroscience Conference Call Participants Jessica Fye - JPMorgan Ami Fadia - SVB Leerink Jason Gerberry - Bank of America Ken Cacciatore - Cowen Balaji Prasad - Barclays Randall Stanicky - RBC Capital Markets Gary Nachman - BMO Capital Markets David Amsellem - Piper Sandler Greg Gilbert - Truist Securities David Risinger - Morgan Stanley Brandon Folkes - Cantor Fitzgerald Esther Rajavelu - UBS David Steinberg - Jefferies Annabel Samimy - Stifel Graig
For further details see:
Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2020 Results - Earnings Call Transcript